Italia markets close in 6 hours 43 minutes

DaVita Inc. (DVA)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
121,11+1,26 (+1,05%)
Alla chiusura: 4:00PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente119,85
Aperto120,45
Denaro0,00 x 1300
Lettera121,41 x 800
Min-Max giorno120,00 - 122,44
Intervallo di 52 settimane80,85 - 136,48
Volume649.123
Media Volume624.176
Capitalizzazione12,684B
Beta (5 anni mensile)1,28
Rapporto PE (ttm)16,29
EPS (ttm)7,43
Prossima data utili27 ott 2021 - 01 nov 2021
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A143,11
  • GlobeNewswire

    Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development

    EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the hiring of Dr. John Barry as Vice President of Research and Development. Dr. Barry will be leading the activities for the development of the Company's transplantable liver and kidney programs including the use of a bio-engineered liver in an

  • GlobeNewswire

    Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys

    The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds and Series C round, led by Baxter, CareDx, and DaVitaEDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced strategic investors invol